Key facts
- SkinIO’s last known valuation is $33.0M (Jun 2025).
- It has raised $15.9M across 5 recorded rounds; the latest was Seed Round ($1.4M) in Sep 2020.
- Notable investors include Matter (Consulting Services (B2B)), Fortson VC, Kenneth Griffin, Stewart Wasson.
- SkinIO has filed 7 Form Ds with the SEC since 2017, most recently Feb 2023 ($1.5M sold to 31 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for SkinIO
Funding rounds
5 roundsAbout SkinIO
Developer of a mobile application-guided full-body imaging system designed to simplify skin disease monitoring and screening. The company's system features an automated, artificial intelligence-based image processing algorithm that specifically looks for moles and lesions on the skin and tracks them over time, enabling dermatologists to detect skin problems in patients and engage them effectively.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2008
- Employees
- 28
- Website
- skinio.com/
- Ownership
- Privately Held (backing)
SkinIO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SkinIO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SkinIO in its N-PORT filings yet. We sweep new filings monthly.